CD274 and neoplasm: Our findings collectively demonstrate that targeting asparagine can significantly influence the composition and function of immune cells within the TME and produce synergistic anti-tumor effects with PD-L1 inhibitors, thereby suggesting a potential strategy for sensitizing GC to immunotherapy.